Advances in Precision Medicine Highlight SPT Week in Review

Article

Top news of the week from Specialty Pharmacy Times.

5. Drug for Rare Form of Rickets Gets FDA Approval

Burosumab (Crysvita, Ultragenyx) is the first treatment approved for x-linked hypophosphatemia in adults and children ages 1 and older.

Click to read more.

4. Study Sheds Light on How HIV Evades the Immune System

HIV targets and disables a pathway involved in blocking viral activity and clearing infection.

Click to read more.

3. High Carbohydrate Diet May Increase Mortality Risk in Certain Cancers

The findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.

Click to read more.

2. Breakthrough Technique Improves Precision of Gene-Editing Technology

A synthetic bridged nucleic acid was found to greatly improve the accuracy of gene-editing technology, which could potentially lead to new therapies for genetic diseases.

Click to read more.

1. New Technology Could Advance Precision Medicine for Cancer, Neurological Disorders

The new method indexes thousands of cells simultaneously and could potentially improve understanding of various diseases at a molecular level.

Click to read more.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.